Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Phase II Trial of the Safety and Efficacy of V-Boost in Patients With Refractory Glioblastoma Multiforme (GBM)

NCT03916757 is registered in ClinicalTrials.gov with Immunitor LLC as lead sponsor.

NCT NCT03916757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03916757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Phase II Trial of the Safety and Efficacy of V-Boost in Patients With Refractory Glioblastoma Multiforme (GBM)
Lead sponsor
Immunitor LLC
Phase
Phase 2
Overall status
Unknown status
Start date
April 16, 2019
Completion date
June 15, 2020
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme, glioma of brain